Search research articles
Contact Us
Filters
Showing results (101-110 of 136) with videos related to
Page
of 14
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 26, 2011
R1507, a monoclonal antibody to the insulin-like growth factor 1 receptor, in patients with recurrent or refractory Ewing sarcoma family of tumors: results of a phase II Sarcoma Alliance for Research through Collaboration study
Alberto S Pappo, Shreyaskumar R Patel, John Crowley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 6, 2021
Treatment of Pediatric Adrenocortical Carcinoma With Surgery, Retroperitoneal Lymph Node Dissection, and Chemotherapy: The Children's Oncology Group ARAR0332 Protocol
Carlos Rodriguez-Galindo, Mark D Krailo, Emilia M Pinto, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 16, 2020
A phase I trial of talazoparib and irinotecan with and without temozolomide in children and young adults with recurrent or refractory solid malignancies
Sara M Federico, Alberto S Pappo, Natasha Sahr, et al.
Cancer
|
May 7, 2014
A phase 2 trial of R1507, a monoclonal antibody to the insulin-like growth factor-1 receptor (IGF-1R), in patients with recurrent or refractory rhabdomyosarcoma, osteosarcoma, synovial sarcoma, and other soft tissue sarcomas: results of a Sarcoma Alliance for Research Through Collaboration study
Alberto S Pappo, Gilles Vassal, John J Crowley, et al.
The Lancet. Oncology
|
December 2, 2019
A risk-based treatment strategy for non-rhabdomyosarcoma soft-tissue sarcomas in patients younger than 30 years (ARST0332): a Children's Oncology Group prospective study
Sheri L Spunt, Lynn Million, Yueh-Yun Chi, et al.
Molecular Cancer Research : MCR
|
January 18, 2019
The Clonal Evolution of Metastatic Osteosarcoma as Shaped by Cisplatin Treatment
Samuel W Brady, Xiaotu Ma, Armita Bahrami, et al.
JAMA
|
March 15, 2012
Association of age at diagnosis and genetic mutations in patients with neuroblastoma
Nai-Kong V Cheung, Jinghui Zhang, Charles Lu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 2, 2012
Treatment outcomes in black and white children with cancer: results from the SEER database and St Jude Children's Research Hospital, 1992 through 2007
Ching-Hon Pui, Deqing Pei, Alberto S Pappo, et al.
JNCI Cancer Spectrum
|
January 17, 2025
Head and neck paraganglioma in Pacak-Zhuang syndrome
Jared S Rosenblum, Yasemin Cole, Danielle Dang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 3, 2025
Erratum: Elective Discontinuation of Larotrectinib in Pediatric Patients With TRK Fusion Sarcomas and Related Mesenchymal Tumors
Leo Mascarenhas, Steven G DuBois, Catherine M Albert, et al.
Page
of 14
Search research articles
Search
Showing results (101-110 of 136) with videos related to
Sort By:
Page
of 14
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 26, 2011
R1507, a monoclonal antibody to the insulin-like growth factor 1 receptor, in patients with recurrent or refractory Ewing sarcoma family of tumors: results of a phase II Sarcoma Alliance for Research through Collaboration study
Alberto S Pappo, Shreyaskumar R Patel, John Crowley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 6, 2021
Treatment of Pediatric Adrenocortical Carcinoma With Surgery, Retroperitoneal Lymph Node Dissection, and Chemotherapy: The Children's Oncology Group ARAR0332 Protocol
Carlos Rodriguez-Galindo, Mark D Krailo, Emilia M Pinto, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 16, 2020
A phase I trial of talazoparib and irinotecan with and without temozolomide in children and young adults with recurrent or refractory solid malignancies
Sara M Federico, Alberto S Pappo, Natasha Sahr, et al.
Cancer
|
May 7, 2014
A phase 2 trial of R1507, a monoclonal antibody to the insulin-like growth factor-1 receptor (IGF-1R), in patients with recurrent or refractory rhabdomyosarcoma, osteosarcoma, synovial sarcoma, and other soft tissue sarcomas: results of a Sarcoma Alliance for Research Through Collaboration study
Alberto S Pappo, Gilles Vassal, John J Crowley, et al.
The Lancet. Oncology
|
December 2, 2019
A risk-based treatment strategy for non-rhabdomyosarcoma soft-tissue sarcomas in patients younger than 30 years (ARST0332): a Children's Oncology Group prospective study
Sheri L Spunt, Lynn Million, Yueh-Yun Chi, et al.
Molecular Cancer Research : MCR
|
January 18, 2019
The Clonal Evolution of Metastatic Osteosarcoma as Shaped by Cisplatin Treatment
Samuel W Brady, Xiaotu Ma, Armita Bahrami, et al.
JAMA
|
March 15, 2012
Association of age at diagnosis and genetic mutations in patients with neuroblastoma
Nai-Kong V Cheung, Jinghui Zhang, Charles Lu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 2, 2012
Treatment outcomes in black and white children with cancer: results from the SEER database and St Jude Children's Research Hospital, 1992 through 2007
Ching-Hon Pui, Deqing Pei, Alberto S Pappo, et al.
JNCI Cancer Spectrum
|
January 17, 2025
Head and neck paraganglioma in Pacak-Zhuang syndrome
Jared S Rosenblum, Yasemin Cole, Danielle Dang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 3, 2025
Erratum: Elective Discontinuation of Larotrectinib in Pediatric Patients With TRK Fusion Sarcomas and Related Mesenchymal Tumors
Leo Mascarenhas, Steven G DuBois, Catherine M Albert, et al.
Page
of 14